Columbia Partners Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11,753
Closed -$3.22M 153
2018
Q1
$3.22M Sell
11,753
-53
-0.4% -$16.5K 0.41% 67
2017
Q4
$3.76M Sell
11,806
-545
-4% -$175K 0.5% 59
2017
Q3
$3.87M Sell
12,351
-6,540
-35% -$1.94M 0.51% 58
2017
Q2
$5.13M Sell
18,891
-811
-4% -$214K 0.65% 39
2017
Q1
$5.39M Sell
19,702
-1,412
-7% -$399K 0.69% 35
2016
Q4
$5.99M Sell
21,114
-4,407
-17% -$1.31M 0.53% 59
2016
Q3
$7.99M Buy
25,521
+3,850
+18% +$1.14M 0.62% 44
2016
Q2
$5.24M Buy
21,671
+12,131
+127% +$3.2M 0.39% 91
2016
Q1
$2.48M Buy
9,540
+26
+0.3% +$6.87K 0.18% 160
2015
Q4
$2.91M Sell
9,514
-20,019
-68% -$5.75M 0.2% 132
2015
Q3
$8.62M Sell
29,533
-18,541
-39% -$6.12M 0.6% 55
2015
Q2
$19.4M Buy
48,074
+3,933
+9% +$1.58M 1.2% 9
2015
Q1
$18.6M Buy
44,141
+5,181
+13% +$2.04M 0.99% 13
2014
Q4
$13.2M Sell
38,960
-365
-0.9% -$118K 0.68% 39
2014
Q3
$13M Buy
39,325
+6,204
+19% +$2.05M 0.66% 41
2014
Q2
$10.4M Sell
33,121
-409
-1% -$123K 0.48% 69
2014
Q1
$10.3M Sell
33,530
-88
-0.3% -$27.9K 0.45% 76
2013
Q4
$9.4M Sell
33,618
-319
-0.9% -$82.5K 0.4% 91
2013
Q3
$8.17M Sell
33,937
-687
-2% -$154K 0.36% 100
2013
Q2
$7.45M Buy
+34,624
New +$7.4M 0.35% 106

Other funds holding BIIB

Columbia Partners Investment Management's BIIB Position: Q2 2018 in Review

Columbia Partners Investment Management sold out of Biogen (BIIB) in Q2 2018, closing a stake of 11,753 shares — an estimated $3.22M sold.

Columbia Partners Investment Management first reported a position in BIIB in Q2 2013 and held it in 20 quarters. The position peaked at $19.4M in Q2 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Columbia Partners Investment Management reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 11,753 Biogen shares in Q2 2018, an estimated $3.22M.
  • Columbia Partners Investment Management first reported a position in Biogen in Q2 2013 and held it in 20 quarters.
  • Columbia Partners Investment Management's Biogen position peaked at $19.4M in Q2 2015.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.